Annual Dinner of Paris Brain Institute America at the French Consulate in New York – A Resounding Success for Neuroscience Research
On October 8, 2024, the French Consulate in New York hosted the annual dinner of Paris Brain Institute America (PBIA), gathering prominent philanthropists and influential figures from the scientific community for an evening dedicated to transatlantic...
10.15.2024
Support
Looking back at the “Brain to Market” Summer School 2024 dedicated to motor neurone disease
From September 9 to 13, the Open Brain School, the education center at Paris Brain Institute, organized the 10th edition of its flagship training program in neuroscience and entrepreneurship—dedicated to fostering innovation. This event brought the...
10.07.2024
Teaching & training
F.P.Journe and Paris Brain Institute celebrate 20 years of partnership with a new collaboration: the RnD Unit F.P.Journe
Paris Brain Institute is proud to be celebrating 20 years of partnership with its first and longest-standing private funder: the watchmaking company F.P.Journe. This partnership, based on shared values of trust, loyalty and excellence, has seen F.P...
09.17.2024
Support
Nikolas Karalis, team leader at the Paris Brain Institute, is awarded the ERC Starting Grant 2024.
The European Research Council's (ERC) Starting Grants are prestigious and highly competitive awards, designed to enable young scientists to build their research team, and to carry out ambitious and innovative projects addressing unexplored scientific...
09.16.2024
Institutional
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them...
09.10.2024
Research, science & health
A special international visit: members and friends of the International Olympic Committee discover Paris Brain Institute
On Wednesday July 31, the Institute had the pleasure of welcoming a special group of visitors: members of the International Olympic Committee (IOC) and their friends and families.
09.08.2024
Institutional
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain...
09.05.2024
Research, science & health
A 7-Tesla MRI machine at Paris Brain Institute - behind the scenes of this incredible technology
It was a long-awaited event. On Sunday June 9, 2024, Paris Brain Institute welcomed an incredible piece of technology into its facilities: the latest generation MAGNETOM Terra X (Siemens Healthineers) 7T MRI. Teams have been doing a great deal of...
08.14.2024
Institutional
EPICA: An immersive training program to boost partnership innovation in health
As part of the Future Investment Program (PIA) and France 2030, the State and the Île-de-France region launched the IFPAI call for projects (Engineering of professional training and innovative support offers) in 2021. The EPICA project is a winner...
07.29.2024
Teaching & training
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol...
07.16.2024
Research, science & health
Paris Brain Institute launches the 2nd edition of NeurAL, its studio startup program dedicated to neuroscience
With support from the Anne and Claude Berda Foundation and from Indosuez Wealth Management, Paris Brain Institute is launching the second edition of NeurAL, its startup studio program.
07.01.2024
Research applications
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024
Research, science & health